🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Placebo to ertugliflozin 15 mg

Found 11 matching trials

A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)

PHASE3

This is a study to evaluate the efficacy and safety of the addition of ertu...

Status

Completed

Location

Multiple Locations

Start Date

2015-12-16

Trial ID

NCT02630706

Treatments Being Tested

Ertugliflozin 5 mg Ertugliflozin 15 mg Placebo matching ertugliflozin Metformin Glimepiride

Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)

PHASE3

This study will evaluate the efficacy and safety of the addition of ertugli...

Status

Completed

Location

Multiple Locations

Start Date

2013-12-16

Trial ID

NCT01999218

Treatments Being Tested

Ertugliflozin 5 mg Ertugliflozin 10 mg Glimerpiride Placebo to Ertugliflozin Placebo to Glimepiride Metformin Sitagliptin

Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)

PHASE3

This study evaluated the safety and efficacy of ertugliflozin (MK-8835) in ...

Status

Completed

Location

The University of Alabama at Birmingham ( Site 2207)

Start Date

2019-10-08

Trial ID

NCT04029480

Treatments Being Tested

Ertugliflozin 5 mg Ertugliflozin 15 mg Placebo to ertugliflozin 15 mg Placebo to ertugliflozin 5 mg Insulin Metformin

A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).

PHASE3

This is an efficacy and safety study of ertugliflozin in participants with ...

Status

Completed

Location

Multiple Locations

Start Date

2013-12-13

Trial ID

NCT02033889

Treatments Being Tested

Ertugliflozin 5 mg Ertugliflozin 15 mg Placebo to Ertugliflozin Glimepiride Placebo to Glimepiride Basal Insulin Metformin

A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)

PHASE3

This study will evaluate the efficacy and safety of ertugliflozin (MK-8835/...

Status

Completed

Location

Multiple Locations

Start Date

2013-12-02

Trial ID

NCT01986855

Treatments Being Tested

Ertugliflozin 5 mg Placebo 5 mg Ertugliflozin 10 mg Placebo 10 mg

Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease, The VERTIS CV Study (MK-8835-004)

PHASE3

An overall study of the cardiovascular outcomes following treatment with er...

Status

Completed

Location

Multiple Locations

Start Date

2013-11-04

Trial ID

NCT01986881

Treatments Being Tested

Ertugliflozin Placebo Glycemic Rescue

A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)

PHASE3

This trial will evaluate the efficacy and safety of ertugliflozin monothera...

Status

Completed

Location

Multiple Locations

Start Date

2013-10-09

Trial ID

NCT01958671

Treatments Being Tested

Ertugliflozin 5 mg Ertugliflozin 10 mg Placebo to Ertugliflozin Metformin Placebo to Metformin Glimepiride

Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)

PHASE3

This is a safety and efficacy study of ertugliflozin (MK-8835/PF-04971729) ...

Status

Completed

Location

Multiple Locations

Start Date

2014-03-12

Trial ID

NCT02036515

Treatments Being Tested

Ertugliflozin 5 mg Ertugliflozin 15 mg Placebo for ertugliflozin 5 mg Metformin Sitagliptin Glimepiride Insulin Placebo for ertugliflozin 10 mg

Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)

PHASE3

This is a study to evaluate the efficacy and safety of ertugliflozin (MK-88...

Status

Completed

Location

Multiple Locations

Start Date

2014-09-23

Trial ID

NCT02226003

Treatments Being Tested

Ertugliflozin Sitagliptin Placebo to Ertugliflozin Placebo to Sitagliptin Glimepiride

Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study.

PHASE4

Current study will render insight in to the role of renal hypoxia in the di...

Status

Completed

Location

VU University Medical Center

Start Date

2020-12-10

Trial ID

NCT04027530

Treatments Being Tested

Ertugliflozin 15 mg

Previous Next